Cargando…
Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer
Tumor immune microenvironment is closely related to tumor initiation, prognosis, and response to immunotherapy. The immune landscapes, number of infiltrating immune cells, and the localization of lymphocytes in the tumor vary in across different types of tumors. The immune contexture in cancer, whic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471962/ https://www.ncbi.nlm.nih.gov/pubmed/30999966 http://dx.doi.org/10.1186/s40880-019-0365-9 |
_version_ | 1783412145669537792 |
---|---|
author | Wu, Tong Wu, Xuan Wang, Hong-Yang Chen, Lei |
author_facet | Wu, Tong Wu, Xuan Wang, Hong-Yang Chen, Lei |
author_sort | Wu, Tong |
collection | PubMed |
description | Tumor immune microenvironment is closely related to tumor initiation, prognosis, and response to immunotherapy. The immune landscapes, number of infiltrating immune cells, and the localization of lymphocytes in the tumor vary in across different types of tumors. The immune contexture in cancer, which is determined by the density, composition, functional state and organization of the leukocyte infiltrate of the tumor, can yield information relevant to the prediction of treatment response and patients’ prognosis. Better understanding of the immune atlas in human tumors have been achieved with the development and application of single-cell analysis technology, which has provided a reference for prognosis, and insights on new targets for immunotherapy. In this review, we summarized the different characteristics of immune contexture in cancer defined by a variety of single-cell techniques, which have enhanced our understanding on the pathophysiology of the tumor microenvironment. We believe that there are much more to be uncovered in this rapidly developing field of medicine, and they will predict the prognosis of cancer patients and guide the rational design of immunotherapies for success in cancer eradication. |
format | Online Article Text |
id | pubmed-6471962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64719622019-04-24 Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer Wu, Tong Wu, Xuan Wang, Hong-Yang Chen, Lei Cancer Commun (Lond) Review Tumor immune microenvironment is closely related to tumor initiation, prognosis, and response to immunotherapy. The immune landscapes, number of infiltrating immune cells, and the localization of lymphocytes in the tumor vary in across different types of tumors. The immune contexture in cancer, which is determined by the density, composition, functional state and organization of the leukocyte infiltrate of the tumor, can yield information relevant to the prediction of treatment response and patients’ prognosis. Better understanding of the immune atlas in human tumors have been achieved with the development and application of single-cell analysis technology, which has provided a reference for prognosis, and insights on new targets for immunotherapy. In this review, we summarized the different characteristics of immune contexture in cancer defined by a variety of single-cell techniques, which have enhanced our understanding on the pathophysiology of the tumor microenvironment. We believe that there are much more to be uncovered in this rapidly developing field of medicine, and they will predict the prognosis of cancer patients and guide the rational design of immunotherapies for success in cancer eradication. BioMed Central 2019-04-18 /pmc/articles/PMC6471962/ /pubmed/30999966 http://dx.doi.org/10.1186/s40880-019-0365-9 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Wu, Tong Wu, Xuan Wang, Hong-Yang Chen, Lei Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer |
title | Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer |
title_full | Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer |
title_fullStr | Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer |
title_full_unstemmed | Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer |
title_short | Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer |
title_sort | immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471962/ https://www.ncbi.nlm.nih.gov/pubmed/30999966 http://dx.doi.org/10.1186/s40880-019-0365-9 |
work_keys_str_mv | AT wutong immunecontexturedefinedbysinglecelltechnologyforprognosispredictionandimmunotherapyguidanceincancer AT wuxuan immunecontexturedefinedbysinglecelltechnologyforprognosispredictionandimmunotherapyguidanceincancer AT wanghongyang immunecontexturedefinedbysinglecelltechnologyforprognosispredictionandimmunotherapyguidanceincancer AT chenlei immunecontexturedefinedbysinglecelltechnologyforprognosispredictionandimmunotherapyguidanceincancer |